Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1982 Feb;45(2):167–173. doi: 10.1038/bjc.1982.29

Prognostic factors in clinical stage I non-seminomatous germ-cell tumours of the testis.

D Raghavan, M J Peckham, E Heyderman, J S Tobias, D E Austin
PMCID: PMC2010890  PMID: 6174137

Abstract

Prognostic factors have been studied in 59 men with clinical Stage I non-seminomatous germ-cell tumours of the testis (NSGCTT) seen at the Royal Marsden Hospital between 1973 and 1978. Fourteen of the patients relapsed, and 45 have remained continuously disease-free. Two factors were identified which showed a significant correlation with relapse following radiotherapy: local extent of the primary tumour, and rate of decline of serum alpha-foetoprotein (AFP) and beta-human chorionic gonadotrophin (hCG) levels following orchidectomy. High serum marker levels at the time of referral after orchidectomy were not prognostically significant per se. The presence of tissue-associated hCG in the primary tumour was not prognostically significant. The results were compared with histology and pathological stage of the primary tumour in patients presenting with lung metastases but no clinical evidence of lymph-node disease. Embryonal carcinoma was more commonly associated with a locally invasive primary tumour and with extralymphatic spread than was teratocarcinoma.

Full text

PDF
167

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Heyderman E. Immunoperoxidase technique in histopathology: applications, methods, and controls. J Clin Pathol. 1979 Oct;32(10):971–978. doi: 10.1136/jcp.32.10.971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Heyderman E., Neville A. M. Letter: Syncytiotrophoblasts in malignant testicular tumours. Lancet. 1976 Jul 10;2(7976):103–103. doi: 10.1016/s0140-6736(76)92325-4. [DOI] [PubMed] [Google Scholar]
  3. Husband J. E., Barrett A., Peckham M. J. Evaluation of computed tomography in the management of testicular teratoma. Br J Urol. 1981 Apr;53(2):179–183. doi: 10.1111/j.1464-410x.1981.tb03162.x. [DOI] [PubMed] [Google Scholar]
  4. Peckham M. J. An appraisal of the role of radiation therapy in the management of nonseminomatous germ-cell tumors of the testis in the era of effective chemotherapy. Cancer Treat Rep. 1979 Sep-Oct;63(9-10):1653–1658. [PubMed] [Google Scholar]
  5. Peckham M. J., Barrett A., McElwain T. J., Hendry W. F., Raghavan D. Non-seminoma germ cell tumours (malignant teratoma) of the testis. Results of treatment and an analysis of prognostic factors. Br J Urol. 1981 Apr;53(2):162–172. doi: 10.1111/j.1464-410x.1981.tb03160.x. [DOI] [PubMed] [Google Scholar]
  6. Peckham M. J., McElwain T. J., Barrett A., Hendry W. F. Combined management of malignant teratoma of the testis. Lancet. 1979 Aug 11;2(8137):267–270. doi: 10.1016/s0140-6736(79)90288-5. [DOI] [PubMed] [Google Scholar]
  7. Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer. 1976 Dec;34(6):585–612. doi: 10.1038/bjc.1976.220. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES